eMIONs: novel genetically engineered nanocages for magnetic hyperthermia cancer therapy
The clinical introduction of magnetic hyperthermia therapy (MHT) has been hindered by current available agents with poor magnetic-to-thermal conversion efficiency and biocompatibility. It is believed that the genetically engineered magnetic nanocages of encapsulin-produced magnetic iron oxide nanoco...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis Group
2021-01-01
|
| Series: | Molecular & Cellular Oncology |
| Assuntos: | |
| Acceso en liña: | http://dx.doi.org/10.1080/23723556.2020.1863739 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|